ProPhase Labs (PRPH) announced that it has received an extension of 180 calendar days from The Nasdaq Stock Market to regain compliance with the Nasdaq’s minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on Nasdaq, following the expiration of the initial 180 calendar days period to regain compliance on June 24, 2025. NASDAQ stated that it based its determination to grant the extension based on the Company meeting all other applicable requirements for initial listing on the Capital Market with the exception of the bid price requirement.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRPH:
- Prophase Labs Appoints Carolina Abenante as Director
- ProPhase Labs announces successful completion of study of BE-Smart test
- ProPhase Labs announces formation of Clinical Science Advisory Board
- ProPhase Labs’ Earnings Call: Strategic Moves Amid Challenges
- ProPhase Labs Reports Q1 2025 Earnings and Strategic Developments